`
`Case: 1:16-cv-00651 Document #: 74 Filed: 12/05/17 Page 1 of 4 PageID #:2424
`Adrenergic Agonists MeSH Descriptor Data 2017
`
`Details
`
`Qualifiers
`
`MeSH Tree Structures
`
`Concepts
`
`MeSH Heading
`Adrenergic Agonists
`Tree Number(s)
`D27.505.519.625.050.100
`D27.505.696.577.050.100
`Unique ID
`D000322
`Annotation
`do not confuse with ADRENERGIC ANTAGONISTS; DF: ADREN AGON or ADREN AG
`Scope Note
`Drugs that bind to and activate adrenergic receptors.
`Entry Version
`ADREN AG
`Entry Term(s)
`Adrenergic Agonist
`Adrenergic Receptor Agonist
`Adrenergic Receptor Agonists
`Adrenomimetics
`Receptor Agonists, Adrenergic
`Registry Number
`
`0N
`
`LM Classification #
`QV 129
`Previous Indexing
`Sympathomimetics (1966-1974)
`Public MeSH Note
`95; was ADRENERGIC RECEPTOR AGONISTS 1975-94
`Online Note
`use ADRENERGIC AGONISTS to search ADRENERGIC RECEPTOR AGONISTS 1975-94
`History Note
`95; was ADRENERGIC RECEPTOR AGONISTS 1975-94
`Date Established
`1975/01/01
`Date of Entry
`1999/01/01
`Revision Date
`2005/06/30
`
`Copyright , Privacy , Accessibility , Site Map , Viewers and Players
`U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
`National Institutes of Health, Health & Human Services, Freedom of Information Act
`
`
`
`Case: 1:16-cv-00651 Document #: 74 Filed: 12/05/17 Page 2 of 4 PageID #:2425
`Adrenergic Agonists MeSH Descriptor Data 2017
`
`Details
`
`Qualifiers
`
`MeSH Tree Structures
`
`Concepts
`
`Allowable Qualifiers
`administration & dosage (AD)
`adverse effects (AE)
`analysis (AN)
`blood (BL)
`cerebrospinal fluid (CF)
`chemical synthesis (CS)
`chemistry (CH)
`classification (CL)
`contraindications (CT)
`economics (EC)
`history (HI)
`immunology (IM)
`isolation & purification (IP)
`metabolism (ME)
`pharmacokinetics (PK)
`pharmacology (PD)
`poisoning (PO)
`radiation effects (RE)
`standards (ST)
`supply & distribution (SD)
`therapeutic use (TU)
`toxicity (TO)
`urine (UR)
`
`Copyright , Privacy , Accessibility , Site Map , Viewers and Players
`U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
`National Institutes of Health, Health & Human Services, Freedom of Information Act
`
`page delivered in 0.181s
`
`
`
`Case: 1:16-cv-00651 Document #: 74 Filed: 12/05/17 Page 3 of 4 PageID #:2426
`Adrenergic Agonists MeSH Descriptor Data 2017
`
`Details
`
`Qualifiers
`
`MeSH Tree Structures
`
`Concepts
`
`Chemical Actions and Uses [D27]
`Pharmacologic Actions [D27.505]
`Molecular Mechanisms of Pharmacological Action [D27.505.519]
`Neurotransmitter Agents [D27.505.519.625]
`Adrenergic Agents [D27.505.519.625.050]
`Adrenergic Agonists [D27.505.519.625.050.100]
`
`Adrenergic alpha-Agonists [D27.505.519.625.050.100.100]
`
`Adrenergic beta-Agonists [D27.505.519.625.050.100.200]
`
`Adrenergic Antagonists [D27.505.519.625.050.200]
`
`Adrenergic Uptake Inhibitors [D27.505.519.625.050.601]
`
`Chemical Actions and Uses [D27]
`Pharmacologic Actions [D27.505]
`Physiological Effects of Drugs [D27.505.696]
`Neurotransmitter Agents [D27.505.696.577]
`Adrenergic Agents [D27.505.696.577.050]
`Adrenergic Agonists [D27.505.696.577.050.100]
`
`Adrenergic alpha-Agonists [D27.505.696.577.050.100.100]
`
`Adrenergic beta-Agonists [D27.505.696.577.050.100.200]
`
`Adrenergic Antagonists [D27.505.696.577.050.200]
`
`Adrenergic Uptake Inhibitors [D27.505.696.577.050.601]
`
`Copyright , Privacy , Accessibility , Site Map , Viewers and Players
`U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
`National Institutes of Health, Health & Human Services, Freedom of Information Act
`
`page delivered in 0.181s
`
`
`
`Case: 1:16-cv-00651 Document #: 74 Filed: 12/05/17 Page 4 of 4 PageID #:2427
`Adrenergic Agonists MeSH Descriptor Data 2017
`
`Details
`
`Qualifiers
`
`MeSH Tree Structures
`
`Concepts
`
`Adrenergic Agonists Preferred
`
`Copyright , Privacy , Accessibility , Site Map , Viewers and Players
`U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
`National Institutes of Health, Health & Human Services, Freedom of Information Act
`
`page delivered in 0.181s
`
`Expand All
`
`